Tissue engineering in androgen deficiency

被引：0
作者：
Aboushwareb T. [1 ]
Yoo J.J. [1 ]
Atala A. [1 ]
机构：
[1] Department of Urology, Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC 27157, Medical Center Boulevard
来源：
Current Sexual Health Reports | 2006年 / 3卷 / 4期
关键词：
Testosterone; Androgen; Testosterone Level; Leydig Cell; Testosterone Replacement;
D O I：
10.1007/s11930-006-0006-6
中图分类号：
学科分类号：
摘要：
Androgen replacement modalities have been associated with various complications, fluctuation of serum testosterone levels, and repeated treatments. Tissue engineering and regenerative medicine strategies, including androgen replacement therapy, provide alternative possibilities for the management of various pathologic tissue conditions. This article presents tissue engineering approaches, which involve the development of androgen supplementation systems for functional androgen replacement. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：161 / 165
页数：4
相关论文
共 28 条
  • [1] Gooren LJ, Bunck MC: Androgen replacement therapy: present and future, Drugs, 64, pp. 1861-1891, (2004)
  • [2] Chen F., Yoo J.J., Atala A., Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair, Urology, 54, pp. 407-410, (1999)
  • [3] Kaufman J.M., Vermeulen A., Declining gonadal function in elderly men, Baillieres Clin Endocrinol Metab, 11, pp. 289-309, (1997)
  • [4] Yoo J.J., Meng J., Oberpenning F., Atala A., Bladder augmentation using allogcnic bladder submucosa seeded with cells, Urology, 51, pp. 221-225, (1998)
  • [5] Hameed A., Brothwood T., Bouloux P., Delivery of testosterone replacement therapy, Curr Opin Investig Drugs, 4, pp. 1213-1219, (2003)
  • [6] Wiebel T., Testosterone replacement in urology], Krankenpfl J, 42, (2004)
  • [7] Dobs A.S., Meikle A.W., Arver S., Et al., Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men, J Clin Endocrinol Metab, 84, pp. 3469-3478, (1999)
  • [8] Atala A., Kim W., Paige K.T., Et al., Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension, J Urol, 152, 2 PART 2, pp. 641-643, (1994)
  • [9] Cilento B.G., Freeman M.R., Schneck F.X., Et al., Phenotypic and cytogenctic characterization of human bladder urothelia expanded in vitro, J Urol, 152, 2 PART 2, pp. 665-670, (1994)
  • [10] Amiel G.E., Atala A., Current and future modalities for functional renal replacement, Urol Clin North Am, 26, pp. 235-246, (1999)
123